In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey


Yildirim F. S., User U., Sari N. D., KURTARAN B., Onlen Y., Senates E., ...Daha Fazla

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.33, sa.11, ss.971-978, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 11
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5152/tjg.2022.21834
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.971-978
  • Anahtar Kelimeler: Drug therapy, drug users, hepatitis C virus, OPIOID AGONIST TREATMENT, VIRUS-INFECTION, GENOTYPE DISTRIBUTION, NATURAL-HISTORY, HCV, USERS, COINFECTION, HIV, THERAPY, SEROPREVALENCE
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background: People who inject drugs (PWID) should be treated in order to eliminate hepatitis C virus in the world. The aim of this study was to compare direct-acting antivirals treatment of hepatitis C virus for PWID and non-PWID in a real-life setting.